Publicaciones en colaboración con investigadores/as de Hospital Infanta Leonor (82)

2024

  1. Antibiotic stewardship programs in the Spanish emergency services: PROA-URG Study

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 163-169

  2. Correction to: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA (Scientific Reports, (2022), 12, 1, (13057), 10.1038/s41598-022-17271-3)

    Scientific Reports

  3. Descriptive Analysis of Carrier and Affected Hereditary Fructose Intolerance in Women during Pregnancy

    Healthcare (Switzerland), Vol. 12, Núm. 5

  4. Design of mobile and website health application devices for drug tolerability in hereditary fructose intolerance

    Orphanet Journal of Rare Diseases, Vol. 19, Núm. 1

2023

  1. AB1352 Impact of Systemic Therapies on the Seroprevalence of Sars-Cov-2 in Patients with Immune-Mediated Diseases

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1907.1-1907

  2. Correction: Vitamin C and folate status in hereditary fructose intolerance (European Journal of Clinical Nutrition, (2022), 76, 12, (1733-1739), 10.1038/s41430-022-01178-3)

    European Journal of Clinical Nutrition

  3. Deglufarm: Mobile application with recommendations for safety drug administration in patients with dysphagia or deglution disorders

    Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 285-288

  4. Drug-related problems as reason for emergency department visit: 3 years of the FARM-URG registry

    International Journal of Pharmacy Practice, Vol. 31, Núm. 4, pp. 417-422

  5. Seroprevalence of SARS-CoV-2 antibodies in patients with immune-mediated inflammatory diseases treated with biological and synthetic targeted therapies

    Revista Chilena de Infectologia, Vol. 40, Núm. 6, pp. 618-625

  6. Usefulness of Preoperative Determination of Serum MR-ProAdrenomedullin Levels to Predict the Need for Postoperative Organ Support in Abdominal Oncological Surgery

    Journal of Personalized Medicine, Vol. 13, Núm. 7

  7. [Translated article] Deglufarm: Mobile application with recommendations for the safe administration of drugs in patients with dysphagia or swallowing disorders

    Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. T285-T288

2022

  1. Análisis coste-utilidad de venetoclax en combinación con obinutuzumab como tratamiento de primera línea de la leucemia linfocítica crónica en España

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 3, pp. 121-132

  2. Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

    Scientific Reports, Vol. 12, Núm. 1

  3. Development and validation of a HPLC-UV method for methadone hydrochloride quantification in a new oral solution with preservatives to be implemented in physicochemical stability studies

    BMC Chemistry, Vol. 16, Núm. 1

  4. Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs-Findings From the BIOCOVID Study

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, Vol. 28, Núm. 2, pp. e348-e352

  5. Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study

    JCR: Journal of Clinical Rheumatology, Vol. 28, Núm. 2, pp. e348-e352

  6. Increased Incidence of In-Hospital Ischemic Stroke During SARS-CoV-2 Outbreak: A Single-Center Study

    Neurocritical Care, Vol. 36, Núm. 1, pp. 208-215

  7. Physicochemical and Microbiological Stability of Two Oral Solutions of Methadone Hydrochloride 10 mg/mL

    Molecules, Vol. 27, Núm. 9

  8. TRAF3 alterations are frequent in del-3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features

    American Journal of Hematology, Vol. 97, Núm. 7, pp. 903-914

  9. Vitamin C and folate status in hereditary fructose intolerance

    European Journal of Clinical Nutrition, Vol. 76, Núm. 12, pp. 1733-1739